Dong Han Kim

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Glycemic Control

Mesenchymal Stem Cells

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Eun Gyoung Hong, Kyung Wan Min, Jung Soo Lim, Kyu Jeong Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study. Advances in therapy 41 (5) (2024)
Eun Gyoung Hong, Kyung Wan Min, Jung Soo Lim, Kyu Jeong Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study. Advances in therapy 41 (5) (2024)
Eun Gyoung Hong, Kyung Wan Min, Jung Soo Lim, Kyu Jeong Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study. Advances in therapy (2024)
Eun Gyoung Hong, Kyung Wan Min, Jung Soo Lim, Kyu Jeong Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study. Advances in therapy 41 (5) (2024)